Circ_0040823 sponges miR-516b to relieve the inhibitory effects of PTEN in AML, thereby inhibiting the expression of cell cycle-related proteins such as cyclin D1 and cyclin E1 and increasing the percentage of cells in the G0/G1 phase [154]. This evidence concerns the gene CCND1 and acute myeloid leukemia.